Article Information
History
- February 23, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- JF Roze*,1,
- GR Monroe1,
- J Kutzera2,
- JW Groeneweg1,
- E Stelloo2,
- ST Paijens3,
- HW Nijman3,
- HS van Meurs4,
- LRCW van Lonkhuijzen4,
- JMJ Piek5,
- CAR Lok6,
- GN Jonges7,
- PO Witteveen8,
- RHM Verheijen1,
- G van Haaften2 and
- RP Zweemer1
- 1Department of Gynaecological Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 2Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Oncode Institute, Utrecht University, Utrecht, The Netherlands
- 3Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- 4Department of Gynecological Oncology, Centre for Gynaecological Oncology Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands
- 5Department of Obstetrics and Gynaecology, Catharina Hospital, Eindhoven, The Netherlands
- 6Department of Gynaecological Oncology, Centre for Gynaecological Oncology Amsterdam, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
- 7Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 8Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- ↵*Corresponding Author:
JF Roze, J.F.Roze{at}umcutrecht.nl, Phone: +31 88-7577257
Posted February 23, 2020.
Whole genome sequencing of ovarian granulosa cell tumors reveals tumor heterogeneity and a high-grade TP53-specific subgroup
